Asia-Pacific
A fresh wave of deals highlights why investors favour IP firms and why independent outfits may soon have to rethink their strategy
Peter O’Sullivan, a professional services executive, says he is looking forward to helping Pearce IP become the leading life sciences firm in Australia and New Zealand
Ranjna Mehta-Dutt, who moved to Chadha & Chadha after 25 years at Remfry & Sagar, says the firm plans to expand its life sciences practice through targeted recruitment and dedicated teams for bigger clients
Law firms across the world are seemingly united in their reluctance to give juniors a chance, which shouldn’t be the case
Sponsored
Sponsored
-
Sponsored by RNA, Technology and IP AttorneysRanjan Narula and Ajay Kumar of RNA Technology and IP Attorneys explore the key takeaways from guidelines introduced to establish fairness in claims and advertisements of food products -
Sponsored by FB RiceBeata Khaidurova and James Coburn of FB Rice delve into a chronology of Australian Patent Office decisions and find a pattern of reasoning which shows that some UIs may be protectable under Australian patent law
-
Sponsored by Liu, Shen & AssociatesYanan Deng and Jinlin Chen of Liu Shen & Associates explain why a good patent portfolio for 5G is so valuable in business
-
Sponsored by Hanol IP & LawMin Son of Hanol IP & Law looks at the changing trend of how courts are determining the similarity of trademarks in South Korea
-
Sponsored by ABE & PartnersTakanori Abe of Abe & Partners looks at a recent judgment which explored how directors are directly liable for the patent infringement of their companies
-
Sponsored by Wanhuida Intellectual PropertyXiaohui Wu and Jianhui Li of Wanhuida Intellectual Property discuss the crystalline form patent application when determining the inventive step
